Literature DB >> 1540781

Cytokines and bone.

B R MacDonald1, M Gowen.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1540781     DOI： 10.1093/rheumatology/31.3.149

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


× No keyword cloud information.
  12 in total

1.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.

Authors:  J Jahnsen; J A Falch; E Aadland; P Mowinckel
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Longitudinal study of bone mineral density in patients with Crohn's disease.

Authors:  D J de Jong; L Mannaerts; L G M van Rossum; F H M Corstens; A H J Naber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Treatment of osteoporosis of rheumatoid arthritis.

Authors:  F P Cantatore; M Carrozzo
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 4.  Basic bone cell biology.

Authors:  A J Freemont
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

5.  Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) patients.

Authors:  G Lisignoli; S Toneguzzi; C Pozzi; A Piacentini; F Grassi; A Ferruzzi; G Gualtieri; A Facchini
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.

Authors:  Simeon Grazio; Zvonko Kusić; Selma Cvijetić; Frane Grubišić; Antonija Balenović; Tomislav Nemčić; Valentina Matijević-Mikelić; Marija Punda; Joachim Sieper
Journal:  Rheumatol Int       Date:  2011-08-20       Impact factor: 2.631

7.  Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus.

Authors:  Y Kipen; R Will; B J Strauss; E F Morand
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 8.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

9.  Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

Authors:  Ali Gur; Bünyamin Dikici; Kemal Nas; Mehmet Bosnak; Kenan Haspolat; Aysegul Jale Sarac
Journal:  BMC Gastroenterol       Date:  2005-09-19       Impact factor: 3.067

10.  Vitamin D levels in patients with ankylosing spondylitis: Is it related to disease activity?

Authors:  Burhan Fatih Kocyigit; Ahmet Akyol
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.